Menu
  • Home
  • Lectures
  • Educational Materials
  • Events
  • Participate
  • Amyloid Reducing Drugs
  • Diversity
  • Publications
More

Amyloid Reducing Drugs

Newly Approved Drugs for Mild Alzheimer's

General: How is Alzheimer's Disease Treated

Aduhelm Updates

Approval Announcements:

Alzheimer's Association and opinion of final decision

Alzheimer's International

Food and Drug Administration 

National Institute on Aging

Center for Medicare and Medicaid Services (CMS)-coverage decision

CMS more detailed information

Consent Guidelines for Treatment

American Academy of Neurology-aducanumab

Opinions from AGREEDementia Members

Developing an Economic and Policy Research Agenda for Blood Biomarkers of Neurodegenerative Diseases

The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA


© 2020 The Advisory Group on Risk Evidence Education for Dementia.
Powered by Webnode